The place of ARBs in heart failure therapy: is aldosterone suppression the key?

Since the launch of the first orally available angiotensin II (AngII) type 1 receptor (AT(1)R) blocker (ARB) losartan (Cozaar) in the late 1990s, the class of ARBs (or ‘sartans’, short for Angiotensin-RecepTor-ANtagonistS) quickly expanded to include candesartan, eprosartan, irbesartan, valsartan, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Markan, Uma, Pasupuleti, Samhitha, Pollard, Celina M., Perez, Arianna, Aukszi, Beatrix, Lymperopoulos, Anastasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691655/
https://www.ncbi.nlm.nih.gov/pubmed/31401939
http://dx.doi.org/10.1177/1753944719868134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691655/
https://www.ncbi.nlm.nih.gov/pubmed/31401939
http://dx.doi.org/10.1177/1753944719868134

Ejemplares similares